PRESS-RELEASE ·Filed Aug 3, 2026

PODD

Robbins LLP
BEARISH
Impact 5/10
Horizonmonths Processed2mo ago WireGlobeNewswire
Press release: m_and_a
Actionable Insight ▼ Bearish

The product recall events are already priced in, but the ongoing class action adds legal overhang. Monitor developments near the August 31 lead plaintiff deadline and any further FDA or regulatory actions regarding Omnipod manufacturing.

DirectionBearish
Confidencemedium
Horizonmonths
Latest settled — T+20d
PODD ▼ -12.40% at T+20d
SHORT call ✓ call won +12.40% · α vs SPY +13.64% · entry $169.70 → $148.66
Next anchor: T+60d in 25d
Latest observation: T+39 +20.21% FF3 residual α
Entry anchored
Aug 3, 10:04 AM ET
via exchange tick
T+1d
-2.24%
call +2.24% · α +4.01%
$165.90
settled 8w ago
T+5d
-15.82%
call +15.82% · α +17.85%
$142.85
settled 8w ago
T+20d
-12.40%
call +12.40% · α +13.64%
$148.66
settled 5w ago
T+60d
—
call — · α —
—
in 25d

Price Chart

Loading chart...

Executive Summary

Robbins LLP reminds Insulet (PODD) investors of a pending securities fraud class action related to manufacturing deficiencies and two Medical Device Corrections for Omnipod products in March and May 2026. The stock fell ~6.88% and ~5.07% on those disclosure dates; the lead plaintiff deadline is August 31, 2026.

Key Facts

  • Class period: February 21, 2025 to May 26, 2026.
  • Two Medical Device Corrections: March 2026 (Omnipod 5) and May 2026 (Omnipod 5, DASH, Eros).
  • Stock fell $16.23 (6.88%) on March 13 and $7.79 (5.07%) on May 27, 2026.
  • Lead plaintiff deadline: August 31, 2026.

Financial Impact

Stock drops of approximately 6.88% and 5.07% already occurred on recall dates; class action seeks unspecified damages.

market capinvestor losses

Risk Factors

  • Further product safety issues or regulatory penalties.
  • Significant litigation costs or settlement payout.
  • Additional corrective actions impacting revenue and brand trust.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (35 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302840812
9 reports for PODD
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +16.86%Jul 3, 2026
Filters
Rows
Reports for PODD — sortable, filterable
TypeNow
Aug 5, 2026
8w ago
8-K
MIXED ★ 5/10
$132.30 $148.14▲ +11.97%▲ +12.57%$131.69 (−0.46%)
Aug 3, 2026
8w ago
Press Release
BEARISH ★ 5/10
$169.70 $148.66▲ +12.40%▲ +13.64%$131.69 (+22.40%)
Jul 30, 2026
9w ago
Press Release
BEARISH ★ 5/10
$165.68 $143.41▲ +13.44%▲ +17.41%$131.69 (+20.52%)
Jul 24, 2026
10w ago
Institutional Cluster
BEARISH ★ 5/10
$163.26 $147.92▲ +9.39%▲ +13.02%$131.69 (+19.34%)
Jul 13, 2026
11w ago
Press Release
NEUTRAL ★ 2/10
$159.12 $144.70▼ −9.06%▼ −11.55%$131.69 (−17.24%)
Jul 3, 2026
12w ago
Press Release
BEARISH ★ 5/10
$159.77 $165.35▼ −3.49%▼ −4.06%$131.69 (+17.58%)
May 28, 2026
18w ago
Court Ruling
BEARISH ★ 7/10
$141.98 $153.82▼ −8.34%▼ −11.03%$131.69 (+7.25%)
May 6, 2026
21w ago
8-K
BULLISH ★ 7/10
$150.52 $143.30▼ −4.80%▼ −7.58%$131.69 (−12.51%)
Mar 4, 2026
30w ago
8-K
NEUTRAL ★ 3/10
$240.55 $204.04▼ −15.18%▼ −11.39%$131.69 (−45.26%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 3, 2026